INCR — Intercure Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1857030 ·
Last close
$0.94
Market Cap
$53.66M
52W High
$1.23
52W Low
$0.72
ADV30
45,668
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 690,552,000 | 46,466,000 | 294,195,000 |
| Dec 2024 | — | — | — | — | 762,574,000 | 78,318,000 | 364,903,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-314,615,000
Inventory
$108,064,000
Receivables
$154,470,000
ST Investments
$209,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 270,200,000 | 6,733,000 | -35,710,000 | 690,552,000 | 294,195,000 | — | 16,841,000 |
| Dec 2024 | 238,845,000 | -45,056,000 | -67,795,000 | 762,574,000 | 364,903,000 | — | -66,926,000 |
| Dec 2023 | 355,553,000 | 37,593,000 | -61,959,000 | 786,614,000 | 329,552,000 | — | -53,631,000 |
| Dec 2022 | 388,684,000 | 41,200,000 | 44,819,000 | 958,007,000 | 436,530,000 | — | 51,267,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.48
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HYPD | HYPERION DEFI, INC. | $53.51M | $3.53 | — |
| KALA | KALA BIO, Inc. | $52.89M | $2.85 | — |
| IMMP | IMMUTEP Ltd | $55.10M | $0.37 | — |
| CNTX | Context Therapeutics Inc. | $55.13M | $0.60 | — |
| CLCS | Cell Source, Inc. | $56.40M | $0.83 | — |
News headlines (Yahoo Finance, 1h cache)
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
2026-06-15 13:25 · Yahoo
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
2026-04-30 22:05 · Yahoo
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
2026-03-03 21:46 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
2026-02-19 12:00 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
2026-02-19 12:00 · Yahoo
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
2025-11-03 13:30 · Yahoo
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
2025-10-08 13:40 · Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$1M
2025-09-29 09:04 · Yahoo
Sector Update: Health Care Stocks Mixed Late Afternoon
2025-09-19 20:02 · Yahoo
InterCure Enters Premium US Cannabis Market With ISHI Deal
2025-09-19 14:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.